ClearPoint Neuro Inc vs Eaton Corporation plc — how do they compare? ClearPoint Neuro Inc trades at $14.95 (market cap $454.21M), while Eaton Corporation plc trades at $463.32 (market cap $172.82B). The key difference: Eaton Corporation plc is far larger — about 380.5× ClearPoint Neuro Inc's market cap, and Eaton Corporation plc pays a 0.99% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| CLPT | ETN | |
|---|---|---|
Market Cap | $454.21M | $172.82B |
Sector | Health | Technology |
52-Week High | $29.60 | $459.29 |
52-Week Low | $8.66 | $315.82 |
Enterprise Value | $488.79M | $193.45B |
Dividend Yield | — | 0.99% |
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $14.56, down slightly by 0.07% today, with a bullish technical signal from moving averages but mixed oscillators. The company reported Q2 2026 revenue growth to $42 million but missed earnings estimates with a loss of $0.38 per share, reflecting ongoing investment in clinical and preclinical services. Despite negative net income margins and cash flow challenges, analyst consensus remains unanimously bullish with 3 buy ratings.
The outlook hinges on successful execution of growth initiatives in neuro drug delivery and regulatory progress with partners, though high valuation multiples and persistent losses pose significant risks. Near-term catalysts include Q3 2026 earnings and partner developments, but investors face volatility from operational cash burn and competitive pressures.
Eaton Corporation (ETN) trades at $468.37, up 5.26% in 24 hours, reflecting strong momentum after recent earnings beats. The stock exhibits a bullish technical trend with support at $456 and resistance at $470. Q2 2026 earnings beat expectations with EPS of $3.15 versus $3.07 estimated, and the company raised its full-year outlook, driven by robust demand in electrical and data center segments.
Outlook remains positive given raised guidance and AI-driven power infrastructure demand, but risks include premium valuation (P/E 45.31) and execution challenges. Analyst consensus is bullish with a $499.75 price target, though investors should monitor competitive pressures and macroeconomic conditions affecting industrial spending.
Trailing returns across standard periods
Latest headlines on both assets
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →Eaton is a global power management company providing energy-efficient solutions for electrical, aerospace, and industrial sectors. It focuses on improving sustainability through intelligent power technology.
Read more on ETN →